MLYS icon

Mineralys Therapeutics (MLYS)

NASDAQ

$26.37

-$0.0100 (

-0.04%

)

1D
5D
1M
6M
1Y
5Y
Pre market

MLYS: $26.37 / ₿ 0.0003 BTC / 34367 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$26.38
$12.59 - $47.65
$2.18B
7.74
$264.00
82.50M
$25.78 - $28.12
Yes

What is Mineralys Therapeutics (MLYS)?

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

The Mineralys Therapeutics (MLYS) stock price has been falling

The Mineralys Therapeutics, Inc. Common Stock (MLYS) stock pre-market price today is $26.37, reflecting a -0.04% pre-market move since the market last closed. The company’s market capitalization stands at $2.18B, with a daily trading volume of $264.00 shares. The previous closing price was $26.38.

Get started with Mineralys Therapeutics (MLYS)

Ready to get started? Follow the steps below, or read our guide on how to buy Mineralys Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy MLYS

Search for MLYS in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy MLYS.

MLYS FAQs

MLYS is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

MLYS is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Mineralys Therapeutics, Inc. Common Stock (MLYS) has traded between a low of $12.59 and a high of $47.65.

MLYS is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Mineralys Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
MLYS icon
MLYS

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

AMST icon

AMST

ORGNW icon
MTVA icon

MTVA

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

VSTD icon

VSTD

BTMWW icon
SAGT icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.